Company News

  • Snibe become the 1st in China who received FDA Cleared on CLIA product

    Release Date:2017-10-27

    14th July 2017- Snibe Co., Ltd. receives the FDA clearance on the commercialization of TSH on MaglumiTM 2000 fully-automatic chemiluminescence immunoassay system. (US FDA 510 (k), K NO. : K162698) .It is the 1st company in China who received FDA cleared on CLIA product.
  • 2019 Medica Invitation

    View Count:229

  • Snibe Shows Great Charms at 71th AACC

    View Count:837

    Snibe brings the latest innovation MAGLUMI X8 to 71st AACC Annual Scientific Meeting & Clinical Lab Expo, with booth No. 1317 in California United States, one of the largest and most influential medical exhibitions across the world, attracting more than 21,000 visitors, and 800 exhibitors dedicated to sharing the most advanced technology available in the IVD, and medical laboratory market.
  • Snibe becomes the 1st in China who receives Anti-HCV CLIA Assays List A CE Mark

    View Count:1167

    July 2019, with the approval of CE mark for Anti-HCV CLIA assay, Snibe has become the 1st company in China to receive CE List A certification for Hepatitis C testing kit In CLIA field.
  • Snibe Shows Great Charms at EuroMedlab 2019 in Barcelona

    View Count:1534

    EuroMedLab Barcelona 2019, the largest exhibition in the field of Clinical Chemistry and Laboratory Medicine in Europe, which attracted more than 5000 participants, was held in Barcelona International Convention Centre (CCIB) from May 19th to 23rd, 2019.
  • Snibe participated in the Medlab Asia Pacific 2019 as a Diamond Sponsor, Singapore

    View Count:1480

    MEDLAB Asia Pacific 2019 is held in Singapore from March 26th to 28th. This is a trade show where several main solutions and products about Medical, Oncology, Healthcare Industry, Cancer, Laboratory, Healthcare System, Clinical Chemistry, Molecular Diagnostics and Laboratory Medicine tend to put on.